Bristol Myers Squibb bags USFDA approval for plaque psoriasis oral treatment Sotyktu Ruchika Sharma12 Sept 2022 1:29 PM ISTPsoriasis is a widely prevalent, chronic, systemic immune-mediated disease.
Novartis plans to shut down Sandoz North Carolina plant by 2023 end Ruchika Sharma12 Sept 2022 12:24 PM ISTZurich: Pharmaceuticals company Novartis plans to close a Sandoz generics plant in Wilson, North Carolina, around the end of 2023, it said on...
Intranasal COVID vaccine: Bharat Biotech seeks DCGI nod for phase 3 study of iNCOVACC in 5-18 age group Ruchika Sharma12 Sept 2022 11:28 AM ISTiNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
Fujifilm India, Paras Healthcare collaborate to bring latest diagnostic technologies in J&K Ruchika Sharma12 Sept 2022 9:00 AM ISTUnder the long-term pact, Fujifilm will supply a wide range of high-end and sophisticated medical devices, including artificial intelligence-based...
Valneva, VBI Vaccines ink pact for Hepatitis B vaccine PreHevbri Ruchika Sharma11 Sept 2022 5:15 PM ISTCambridge, Mass.: Valneva SE and VBI Vaccines Inc. have announced a partnership in select European markets for the marketing and distribution of...
Pfizer COVID vaccine approved for kids under 5 in Canada MD Bureau11 Sept 2022 3:46 PM ISTIt's the second vaccine approved for that age group after Health Canada approved Moderna's Spikevax in July.
Novartis Kisqali adds one more year of survival benefit for broadest set of patients, including those with aggressive HR+/HER2- advanced breast cancer Ruchika Sharma11 Sept 2022 3:18 PM ISTBasel: Pharma major, Novartis, has announced results from a new pooled exploratory analysis across the entire MONALEESA Phase III program,...
AstraZeneca Lynparza shows clinically meaningful survival benefit in 1st-line advanced ovarian cancer across two Phase III trials Ruchika Sharma11 Sept 2022 1:15 PM ISTOvarian cancer is one of the most common gynaecologic cancers, with a poor prognosis and a high mortality rate.
Bayer, Regeneron anti-blindness drug Eylea shown to work at higher dose, longer intervals Ruchika Sharma11 Sept 2022 9:00 AM ISTFrankfurt: Bayer said on Thursday that its anti-blindness treatment Eylea, jointly developed with Regeneron, was shown to work as well when given...
USFDA accepts regulatory submission for Pfizer alopecia areata treatment Ritlecitinib Ruchika Sharma10 Sept 2022 5:15 PM ISTAlopecia areata is an autoimmune disease that has an underlying immuno-inflammatory pathogenesis and develops when the immune system attacks the...
Gambia probes suspected paracetamol syrup link to dozens of child deaths Ruchika Sharma10 Sept 2022 2:59 PM IST"Dozens of children have died in the last three months," Bittaye told Reuters by phone. "Autopsies suggest the possibility of paracetamol."
Sanofi, Regeneron Pharma announce positive Phase 3 data for Dupixent in adults with uncontrolled prurigo nodularis Ruchika Sharma10 Sept 2022 12:56 PM ISTPeople with prurigo nodularis experience intense, persistent itch, with thick skin lesions (called nodules) that can cover most of the body.
